Meeder Asset Management’s Fennec Pharmaceuticals FENC Stock Holding History

Meeder Asset Management’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,310	Closed	-$8K	–	1986
2020 Q3	$8K	Hold	1,310	–	–	﹤0.01%	1434
2020 Q2	$11K	Sell	1,310 -530	-29%	-$3.94K	﹤0.01%	1285
2020 Q1	$11K	Sell	1,840 -4,914	-73%	-$32.1K	﹤0.01%	1471
2019 Q4	$43K	Hold	6,754	–	–	﹤0.01%	1065
2019 Q3	$32K	Buy	6,754 +2,045	+43%	+$9.03K	﹤0.01%	1160
2019 Q2	$19K	Sell	4,709 -4,595	-49%	-$19.5K	﹤0.01%	1250
2019 Q1	$44K	Sell	9,304 -436	-4%	-$2.87K	﹤0.01%	904
2018 Q4	$62K	Buy	9,740 +736	+8%	+$5.14K	0.01%	758
2018 Q3	$75K	Buy	+9,004	New	+$83.5K	0.01%	699

Other funds holding FENC

SCA

Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return

SFI

Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Meeder Asset Management's FENC Position: Q4 2020 in Review

Meeder Asset Management sold out of Fennec Pharmaceuticals (FENC) in Q4 2020, closing a stake of 1,310 shares — an estimated $8K sold.

Meeder Asset Management first reported a position in FENC in Q3 2018 and held it in 9 quarters. The position peaked at $75K in Q3 2018. 52 funds tracked by Wall St. Rank hold FENC as of Q4 2020.

Meeder Asset Management reported no remaining Fennec Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Meeder Asset Management sold 1,310 Fennec Pharmaceuticals shares in Q4 2020, an estimated $8K.
Meeder Asset Management first reported a position in Fennec Pharmaceuticals in Q3 2018 and held it in 9 quarters.
Meeder Asset Management's Fennec Pharmaceuticals position peaked at $75K in Q3 2018.
52 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.